Key result
Machine learning-based conditional average treatment effect models successfully identified responders to prophylactic dexamethasone for postoperative nausea and vomiting, achieving an AUUC of 22.4.
Why the study?
Risk-based strategies guide prophylaxis for postoperative nausea and vomiting, but whether risk correlates with individual treatment effect remains uncertain.
Does dexamethasone reduce postoperative nausea and vomiting in adult patients undergoing general anesthesia?
Cohort (n=2,026)
No
Does dexamethasone reduce postoperative nausea and vomiting in adult patients undergoing general anesthesia?
Machine learning-based conditional average treatment effect models can identify individual responders to prophylactic dexamethasone for PONV, whereas conventional predicted risk does not correlate with individual treatment response.
Answers are grounded in this paper and cite their sources.
ML CATE models may identify PONV responders to dexamethasone; leaves open prospective validation before clinical use.
Risk-based strategies are widely used for decision making in the prophylaxis of postoperative nausea and vomiting (PONV), a major complication of general anesthesia. However, whether risk is associated with individual treatment effect remains uncertain. Here, we used machine learning-based algorithms for estimating the conditional average treatment effect (CATE) (double machine learning [DML], doubly robust [DR] learner, forest DML, and generalized random forest) to predict the treatment response heterogeneity of dexamethasone, the first choice for prophylactic antiemetics. Electronic health record data of 2026 adult patients who underwent general anesthesia from January to June 2020 were analyzed. The results indicated that only a small subset of patients respond to dexamethasone treatment, and many patients may be non-responders. Estimated CATE did not correlate with predicted risk, suggesting that risk may not be associated with individual treatment responses. The current study suggests that predicting treatment responders by CATE models may be more appropriate for clinical decision making than conventional risk-based strategy.
No takes yet. Share an insight, caveat, or question.
Mizuguchi et al. (2023) conducted a cohort in Postoperative nausea and vomiting (PONV) (n=2,026). Dexamethasone vs. No dexamethasone was evaluated on Area under the uplift curve (AUUC) for identifying treatment responders using Double Machine Learning (DML) (AUUC 22.4, 95% CI 6.4-38.5). Machine learning-based conditional average treatment effect models successfully identified responders to prophylactic dexamethasone for postoperative nausea and vomiting, achieving an AUUC of 22.4.
Synapse has enriched 10 related papers. Consider them for comparative context: